Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962415 · ClinicalTrials.gov registry record · Phase 2
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
A Phase 2 study of Juvenile Rheumatoid Arthritis (JRA) and Primary Immunodeficiency (PID), sponsored by Paul Szabolcs.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01962415 is a Phase 2 study of Juvenile Rheumatoid Arthritis (JRA) and Primary Immunodeficiency (PID) that is actively recruiting participants, run by Paul Szabolcs. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01962415, a Phase 2 study of Juvenile Rheumatoid Arthritis (JRA) and Primary Immunodeficiency (PID), is actively recruiting participants, sponsored by Paul Szabolcs.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). After transplant, subjects will be followed for late effects and for ongoing graft success.
Conditions Studied
Interventions
- DRUG Fludarabine
- DRUG Melphalan
- DRUG Alemtuzumab
- DRUG Hydroxyurea
- DRUG Thiotepa
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-02-04 |
| Est. Completion | 2027-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01962415
The ClinicalTrials.gov registry entry for NCT01962415 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul Szabolcs, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Juvenile Rheumatoid Arthritis (JRA) appearing as the primary indexed condition, and to 5 interventions - of which Fludarabine is the first listed.
NCT01962415 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01962415 about?
NCT01962415 is a clinical study titled "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT". The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non...
What is the current status of trial NCT01962415?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2014-02-04. Estimated completion is 2027-11.
What conditions does trial NCT01962415 study?
This clinical trial studies the following conditions: Juvenile Rheumatoid Arthritis (JRA), Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias.
What interventions are being tested in trial NCT01962415?
The interventions under investigation include: Fludarabine (DRUG), Melphalan (DRUG), Alemtuzumab (DRUG), Hydroxyurea (DRUG), Thiotepa (DRUG).
Who is sponsoring clinical trial NCT01962415?
This trial is sponsored by Paul Szabolcs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01962415 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juvenile Rheumatoid Arthritis (JRA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Juvenile Rheumatoid Arthritis (JRA)
All registered trials for this condition
Primary Immunodeficiency (PID)
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.